Activation of the Mechanistic Target of Rapamycin in SLE: Explosion of Evidence in the Last Five Years
Crossref DOI link: https://doi.org/10.1007/s11926-016-0622-8
Published Online: 2016-11-03
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Oaks, Zachary
Winans, Thomas
Huang, Nick
Banki, Katalin
Perl, Andras
Funding for this research was provided by:
Pfizer (P0468X1-4470/WS1234172)
License valid from 2016-11-03